Fundz

Viking Therapeutics, Inc. reported raising in an initial SEC Form D filing, from an offering of $3.66 Million

PUBLIC · VKTXJun 22, 2017$0 of $3.7M raised

Round Type

Venture

San DiegoBiotechnology

Quick answer

Viking Therapeutics raised an undisclosed amount in a funding round, dated June 22, 2017. Viking Therapeutics is based in San Diego, California, United States.

How much did Viking Therapeutics raise?
Viking Therapeutics raised an undisclosed amount in a funding round on June 22, 2017.
What does Viking Therapeutics do?
Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel 1st-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders,..
Where is Viking Therapeutics based and how big is it?
Viking Therapeutics is based in San Diego, California, United States. Fundz records about 45 employees.
Who are the decision-makers at Viking Therapeutics?
Fundz holds 1 contact at Viking Therapeutics, including the Chief Operating Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Viking Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • UbiVac raised $200K (Pre-Seed) on August 4, 2017.
  • OXOS Medical raised $150K (Seed) on August 4, 2017.
  • ALAMAB THERAPEUTICS INC. raised $12M on August 4, 2017.
  • Amylyx Pharmaceuticals raised $1.8M (Seed) on August 4, 2017.
  • Poseida Therapeutics, Inc. raised $11M on August 3, 2017.
  • NeuroOne Medical Technologies Corporation raised an undisclosed amount on August 2, 2017.

Who to call at Viking Therapeutics, and when

A new round usually means Viking Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Viking Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Viking Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Viking Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Viking Therapeutics

Location

9920 Pacific Heights Blvd,, Suite 350

San Diego, California, United States

About

Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel 1st-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with two programs currently in clinical trials. Viking's clinical programs include VK2735, a novel dual agonist of the GLP-1 and GIP receptors for the potential treatment of various metabolic disorders. Data from a Phase 1 and a Phase 2 trial evaluating VK2735 (dosed subcutaneously) for metabolic disorders demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in a Phase 2 trial.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Viking Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMarianne M., Chief Operating OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Viking Therapeutics's next move

See what Strategic adds

Viking Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.